Literature DB >> 8216245

Increased replication of simian immunodeficiency virus in CEM x174 cells by morphine sulfate.

L F Chuang1, K F Killam, R Y Chuang.   

Abstract

Infection with simian immunodeficiency virus induces cytopathic effects on CEM x174 cells in vitro. Syncytium formation of SIV-infected CEM x174 cells was significantly enhanced in the presence of morphine sulfate, with a concomitant increase in the activity of cellular reverse transcriptase and in the expression of SIV p27 core antigen. Parallel establishment of the viability of the morphine-treated cells indicates that the short-acting opioid protects against cell lysis induced by SIV so that replication and production of SIV particles continued and exceeded those without morphine treatment. This delayed cell lysis induced by morphine as seen in vitro correlated with an in vivo observation that peripheral blood mononuclear cells isolated from morphine-treated rhesus macaques displayed a less degree of programmed cell death by apoptosis during early stages of SIVmac infection. These studies suggest that the modification of the biological properties of HIV-infected cells by morphine sulfate may be one of the mechanisms by which opioids exacerbate the progression of HIV in drug abusers.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8216245     DOI: 10.1006/bbrc.1993.2167

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

Review 1.  Opioids and HIV/HCV infection.

Authors:  Xu Wang; Ting Zhang; Wen-Zhe Ho
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-14       Impact factor: 4.147

Review 2.  Role of mu-opioids as cofactors in human immunodeficiency virus type 1 disease progression and neuropathogenesis.

Authors:  Anupam Banerjee; Marianne Strazza; Brian Wigdahl; Vanessa Pirrone; Olimpia Meucci; Michael R Nonnemacher
Journal:  J Neurovirol       Date:  2011-07-07       Impact factor: 2.643

Review 3.  Substance abuse, HIV-1 and hepatitis.

Authors:  Nirzari Parikh; Michael R Nonnemacher; Vanessa Pirrone; Timothy Block; Anand Mehta; Brian Wigdahl
Journal:  Curr HIV Res       Date:  2012-10       Impact factor: 1.581

Review 4.  Drugs of abuse and HIV infection/replication: implications for mother-fetus transmission.

Authors:  Xu Wang; Wen-Zhe Ho
Journal:  Life Sci       Date:  2010-11-04       Impact factor: 5.037

Review 5.  The impact of substance abuse on HIV-mediated neuropathogenesis in the current ART era.

Authors:  Vanessa Chilunda; Tina M Calderon; Pablo Martinez-Aguado; Joan W Berman
Journal:  Brain Res       Date:  2019-08-29       Impact factor: 3.252

6.  Activation of caspases and p53 by bovine herpesvirus 1 infection results in programmed cell death and efficient virus release.

Authors:  L R Devireddy; C J Jones
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

7.  Morphine enhances HIV infection of neonatal macrophages.

Authors:  Yuan Li; Jeffrey D Merrill; Kathy Mooney; Li Song; Xu Wang; Chang-Jiang Guo; Rashmin C Savani; David S Metzger; Steven D Douglas; Wen-Zhe Ho
Journal:  Pediatr Res       Date:  2003-05-07       Impact factor: 3.756

Review 8.  Morphine and rapid disease progression in nonhuman primate model of AIDS: inverse correlation between disease progression and virus evolution.

Authors:  Vanessa Rivera-Amill; Peter S Silverstein; Richard J Noel; Santosh Kumar; Anil Kumar
Journal:  J Neuroimmune Pharmacol       Date:  2009-12-16       Impact factor: 4.147

9.  Rhesus macaque model of chronic opiate dependence and neuro-AIDS: longitudinal assessment of auditory brainstem responses and visual evoked potentials.

Authors:  Mariam Riazi; Joanne K Marcario; Frank K Samson; Himanshu Kenjale; Istvan Adany; Vincent Staggs; Emily Ledford; Janet Marquis; Opendra Narayan; Paul D Cheney
Journal:  J Neuroimmune Pharmacol       Date:  2009-03-13       Impact factor: 4.147

Review 10.  Opiates, immune system, acquired immunodeficiency syndrome, and nonhuman primate model.

Authors:  Richard J Noel; Vanessa Rivera-Amill; Shilpa Buch; Anil Kumar
Journal:  J Neurovirol       Date:  2008-08       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.